Virtu Financial LLC Uro Gen Pharma Ltd. Transaction History

Virtu Financial LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 30, 2018	SELL	$48.35 - $65.33 $651,999 - $880,975	-13,485 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$48.35 - $65.33 $282,750 - $382,049	5,848 Added 76.57%	13,485 $671,000
Q1 2018 May 14, 2018	BUY	$38.64 - $57.54 $295,093 - $439,432	7,637 New	7,637 $379,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $251M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.